| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 8.3% | $38,241,334 | 6,070,053 | BlackRock, Inc. | 31 Dec 2024 | |||
| Deep Track Capital, LP | 6.9% | -16% | $64,845,000 | -$11,790,000 | 5,500,000 | -15% | Deep Track Capital, LP | 30 Sep 2025 |
As of 31 Dec 2025, 138 institutional investors reported holding 27,315,671 shares of Mind Medicine (MindMed) Inc. - Common Shares (MNMD). This represents 34% of the company’s total 80,058,224 outstanding shares.
The largest institutional shareholders of Mind Medicine (MindMed) Inc. - Common Shares (MNMD) together control 58% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 10% | 8,273,276 | +39% | 0% | $110,779,164 |
| Avoro Capital Advisors LLC | 6.2% | 5,000,000 | 0.66% | $66,950,000 | |
| VANGUARD GROUP INC | 3.2% | 2,591,901 | +29% | 0% | $34,705,554 |
| Trails Edge Capital Partners, LP | 3.2% | 2,568,110 | 0% | 8.5% | $34,386,993 |
| JANUS HENDERSON GROUP PLC | 3% | 2,411,696 | +8513% | 0.01% | $32,256,434 |
| STATE STREET CORP | 3% | 2,368,066 | +23% | 0% | $31,708,404 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.9% | 2,332,938 | +28% | 0% | $31,244,186 |
| Octagon Capital Advisors LP | 2.8% | 2,230,000 | +4.7% | 3.7% | $29,859,700 |
| Blackstone Inc. | 2.6% | 2,059,805 | -26% | 0.12% | $27,580,789 |
| Commodore Capital LP | 2.5% | 2,000,000 | -38% | 1.8% | $26,780,000 |
| Deep Track Capital, LP | 2.1% | 1,676,540 | +12% | 0.51% | $22,448,871 |
| MILLENNIUM MANAGEMENT LLC | 1.7% | 1,383,175 | +364% | 0.01% | $18,520,713 |
| Balyasny Asset Management L.P. | 1.6% | 1,308,115 | 0.03% | $17,515,660 | |
| ORBIMED ADVISORS LLC | 1.5% | 1,226,700 | +234% | 0.35% | $16,425,513 |
| WELLINGTON MANAGEMENT GROUP LLP | 1.5% | 1,220,667 | +376% | 0% | $16,344,731 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.4% | 1,150,000 | +283% | 0.02% | $15,398,500 |
| Candriam S.C.A. | 1.2% | 971,218 | 0.07% | $13,005,163 | |
| GOLDMAN SACHS GROUP INC | 1.2% | 925,332 | +68% | 0% | $12,390,196 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1% | 807,249 | +27% | 0% | $10,809,064 |
| Siren, L.L.C. | 1% | 800,000 | 0.32% | $10,712,000 | |
| Rosalind Advisors, Inc. | 0.94% | 750,000 | 0% | 3.8% | $10,042,500 |
| NORTHERN TRUST CORP | 0.92% | 734,660 | +17% | 0% | $9,837,099 |
| UBS Group AG | 0.85% | 683,802 | +24% | 0% | $9,156,108 |
| Vestal Point Capital, LP | 0.8% | 637,000 | 0.31% | $8,529,430 | |
| Boxer Capital Management, LLC | 0.75% | 598,500 | +266% | 1.8% | $8,013,915 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 27,315,671 | $365,783,934 | +$65,120,703 | $13.39 | 138 |
| 2025 Q3 | 39,739,020 | $468,541,734 | -$19,277,990 | $11.79 | 192 |
| 2025 Q2 | 41,724,953 | $270,804,847 | +$4,339,707 | $6.49 | 175 |
| 2025 Q1 | 41,095,554 | $240,392,825 | -$3,662,052 | $5.85 | 185 |
| 2024 Q4 | 41,502,097 | $288,852,866 | -$56,713,087 | $6.96 | 169 |
| 2024 Q3 | 49,467,087 | $281,475,376 | +$41,724,154 | $5.69 | 152 |
| 2024 Q2 | 41,513,100 | $299,296,365 | +$37,920,056 | $7.21 | 144 |
| 2024 Q1 | 34,806,123 | $327,171,156 | +$283,809,705 | $9.40 | 124 |
| 2023 Q4 | 4,883,412 | $17,868,274 | +$3,722,704 | $3.66 | 98 |
| 2023 Q3 | 3,876,453 | $12,134,312 | -$422,206 | $3.13 | 89 |
| 2023 Q2 | 3,888,536 | $13,881,060 | -$142,348 | $3.57 | 76 |
| 2023 Q1 | 3,960,288 | $12,554,295 | -$1,779,097 | $3.17 | 77 |
| 2022 Q4 | 4,957,575 | $10,906,025 | +$1,924,410 | $2.20 | 85 |
| 2022 Q3 | 3,759,927 | $13,154,091 | +$13,154,091 | $3.50 | 57 |
| 2022 Q1 | 0 | $0 | -$18,000 | $13.88 | 0 |
| 2021 Q4 | 13,006 | $18,000 | $1.38 | 1 | |
| 2021 Q3 | 0 | $0 | -$483,000 | $13.88 | 0 |
| 2021 Q2 | 140,000 | $483,000 | +$483,000 | $3.45 | 1 |